Labcorp Retained Earnings (Accumulated Deficit) 2010-2024 | LH
Labcorp retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Labcorp retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $8.276B, a 2.56% increase year-over-year.
- Labcorp retained earnings (accumulated deficit) for 2023 were $7.888B, a 25.45% decline from 2022.
- Labcorp retained earnings (accumulated deficit) for 2022 were $10.582B, a 1.19% increase from 2021.
- Labcorp retained earnings (accumulated deficit) for 2021 were $10.457B, a 10.31% increase from 2020.
Labcorp Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2023 |
$7,888 |
| 2022 |
$10,582 |
| 2021 |
$10,457 |
| 2020 |
$9,479 |
| 2019 |
$7,904 |
| 2018 |
$7,080 |
| 2017 |
$6,196 |
| 2016 |
$4,956 |
| 2015 |
$4,224 |
| 2014 |
$3,786 |
| 2013 |
$3,374 |
| 2012 |
$3,589 |
| 2011 |
$3,387 |
| 2010 |
$3,247 |
| 2009 |
$2,928 |
Labcorp Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024-09-30 |
$8,276 |
| 2024-06-30 |
$8,178 |
| 2024-03-31 |
$8,055 |
| 2023-12-31 |
$7,888 |
| 2023-09-30 |
$8,070 |
| 2023-06-30 |
$8,836 |
| 2023-03-31 |
$10,730 |
| 2022-12-31 |
$10,582 |
| 2022-09-30 |
$10,845 |
| 2022-06-30 |
$10,898 |
| 2022-03-31 |
$10,948 |
| 2021-12-31 |
$10,457 |
| 2021-09-30 |
$10,787 |
| 2021-06-30 |
$10,417 |
| 2021-03-31 |
$10,172 |
| 2020-12-31 |
$9,479 |
| 2020-09-30 |
$8,464 |
| 2020-06-30 |
$7,761 |
| 2020-03-31 |
$7,529 |
| 2019-12-31 |
$7,904 |
| 2019-09-30 |
$7,677 |
| 2019-06-30 |
$7,456 |
| 2019-03-31 |
$7,265 |
| 2018-12-31 |
$7,080 |
| 2018-09-30 |
$6,922 |
| 2018-06-30 |
$6,603 |
| 2018-03-31 |
$6,369 |
| 2017-12-31 |
$6,196 |
| 2017-09-30 |
$5,517 |
| 2017-06-30 |
$5,337 |
| 2017-03-31 |
$5,148 |
| 2016-12-31 |
$4,956 |
| 2016-09-30 |
$4,771 |
| 2016-06-30 |
$4,581 |
| 2016-03-31 |
$4,383 |
| 2015-12-31 |
$4,224 |
| 2015-09-30 |
$4,109 |
| 2015-06-30 |
$3,956 |
| 2015-03-31 |
$3,787 |
| 2014-12-31 |
$3,786 |
| 2014-09-30 |
$3,686 |
| 2014-06-30 |
$3,553 |
| 2014-03-31 |
$3,409 |
| 2013-12-31 |
$3,374 |
| 2013-09-30 |
$3,462 |
| 2013-06-30 |
$3,575 |
| 2013-03-31 |
$3,668 |
| 2012-12-31 |
$3,589 |
| 2012-09-30 |
$3,588 |
| 2012-06-30 |
$3,523 |
| 2012-03-31 |
$3,470 |
| 2011-12-31 |
$3,387 |
| 2011-09-30 |
$3,402 |
| 2011-06-30 |
$3,327 |
| 2011-03-31 |
$3,204 |
| 2010-12-31 |
$3,247 |
| 2010-09-30 |
$3,115 |
| 2010-06-30 |
$3,073 |
| 2010-03-31 |
$3,003 |
| 2009-12-31 |
$2,928 |
| 2009-09-30 |
$2,785 |
| 2009-06-30 |
$2,654 |
| 2009-03-31 |
$2,517 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$20.273B |
$12.162B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
